April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Initial Clinical Results Of Co2-laser In Deep Sclerectomy
Author Affiliations & Notes
  • Sylvain Roy
    Glaucoma Unit, Swiss Fed Inst of Technology, Lausanne, Switzerland
  • Michael Feusier
    Glaucoma Center, Clinique de Montchoisi, Lausanne, Switzerland
  • Delphine Bifrare
    Glaucoma Center, Clinique de Montchoisi, Lausanne, Switzerland
  • Andre Mermoud
    Glaucoma Center, Clinique de Montchoisi, Lausanne, Switzerland
  • Footnotes
    Commercial Relationships  Sylvain Roy, None; Michael Feusier, None; Delphine Bifrare, None; Andre Mermoud, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2615. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sylvain Roy, Michael Feusier, Delphine Bifrare, Andre Mermoud; Initial Clinical Results Of Co2-laser In Deep Sclerectomy. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2615.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To evaluate the efficacy and safety profile of a CO2-laser ablation system in non-penetrating glaucoma surgery.

Methods: : From July 2010 until October 2010 10 eyes from 10 patients suffering from glaucoma have been operated using a CO2-laser ablation system. After a superficial scleral flap was performed a square-shaped deep scleral space was created by CO2-laser ablation. Depth of ablation was limited before reaching the choroidal layer. For the ablation of the inner wall of Schlemm’s canal, an arc-shaped profile was used. Laser treatment was controlled upon oozing of aqueous humour. After sufficient tissue removal was achieved and an efficient drainage was obtained, the scleral flap and the conjunctiva were then sutured. The main outcomes were the mean intraocular pressure (IOP), the mean number of antiglaucoma medication, the number of postoperative complications.

Results: : For the 10 eyes the mean age at surgery was 48.2 ± 32.3 years, the mean follow-up was 3.5 ± 1.0 months, the mean preoperative IOP was 20.5 ± 5.3 mmHg, the mean visual acuity was 0.8 ± 0.3 and the mean number of antiglaucoma medication before surgery was 3.2 ± 1.2. At final follow-up visits, the mean IOP went down to 13.2 ± 8.5 mmHg (p<0.005), the mean visual acuity was 0.7 ± 0.3 and the mean number of antiglaucoma medication was reduced to 0.2 ± 0.4 (p<0.005). The filtering bleb was visible on 9 eyes (90%). Overall 5 complications were reported, among which 4 were iris incarceration after goniopuncture and 1 was angle closure glaucoma. Complete success rate (IOP ≤ 18 mmHg without antiglaucoma medication) was 70% and the qualified success rate (IOP ≤ 18 mmHg with and without antiglaucoma medication) was 90%.

Conclusions: : A new technique using a CO2-laser ablation system allows precise and easy creation of the scleral space and ablation of Schlemm’s canal. This would render the deep-sclerectomy an easier glaucoma surgery with less complication. From this study the IOP was significantly lowered with less glaucoma medication.

Keywords: laser • intraocular pressure • anterior segment 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.